Free Trial

Microbot Medical (MBOT) Competitors

Microbot Medical logo
$2.67 -0.13 (-4.64%)
Closing price 10/21/2025 04:00 PM Eastern
Extended Trading
$2.59 -0.08 (-3.00%)
As of 05:49 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

MBOT vs. CLPT, SIBN, BVS, ZIMV, BFLY, AVNS, CBLL, KIDS, DCTH, and TMCI

Should you be buying Microbot Medical stock or one of its competitors? The main competitors of Microbot Medical include ClearPoint Neuro (CLPT), SiBone (SIBN), Bioventus (BVS), ZimVie (ZIMV), Butterfly Network (BFLY), AVANOS MEDICAL (AVNS), CeriBell (CBLL), OrthoPediatrics (KIDS), Delcath Systems (DCTH), and Treace Medical Concepts (TMCI). These companies are all part of the "medical equipment" industry.

Microbot Medical vs. Its Competitors

ClearPoint Neuro (NASDAQ:CLPT) and Microbot Medical (NASDAQ:MBOT) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, analyst recommendations, risk, valuation, earnings, dividends, media sentiment and profitability.

30.1% of ClearPoint Neuro shares are held by institutional investors. Comparatively, 16.3% of Microbot Medical shares are held by institutional investors. 6.1% of ClearPoint Neuro shares are held by company insiders. Comparatively, 4.7% of Microbot Medical shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

ClearPoint Neuro currently has a consensus target price of $19.67, suggesting a potential downside of 21.27%. Microbot Medical has a consensus target price of $12.00, suggesting a potential upside of 349.44%. Given Microbot Medical's higher probable upside, analysts plainly believe Microbot Medical is more favorable than ClearPoint Neuro.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
ClearPoint Neuro
1 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.50
Microbot Medical
1 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00

In the previous week, Microbot Medical had 3 more articles in the media than ClearPoint Neuro. MarketBeat recorded 7 mentions for Microbot Medical and 4 mentions for ClearPoint Neuro. Microbot Medical's average media sentiment score of 0.83 beat ClearPoint Neuro's score of 0.75 indicating that Microbot Medical is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
ClearPoint Neuro
2 Very Positive mention(s)
2 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Microbot Medical
3 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Microbot Medical has lower revenue, but higher earnings than ClearPoint Neuro. ClearPoint Neuro is trading at a lower price-to-earnings ratio than Microbot Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
ClearPoint Neuro$31.39M22.62-$18.91M-$0.81-30.84
Microbot MedicalN/AN/A-$11.44M-$0.58-4.60

ClearPoint Neuro has a beta of 1.19, suggesting that its share price is 19% more volatile than the S&P 500. Comparatively, Microbot Medical has a beta of 1.25, suggesting that its share price is 25% more volatile than the S&P 500.

Microbot Medical has a net margin of 0.00% compared to ClearPoint Neuro's net margin of -66.15%. Microbot Medical's return on equity of -76.27% beat ClearPoint Neuro's return on equity.

Company Net Margins Return on Equity Return on Assets
ClearPoint Neuro-66.15% -94.44% -51.58%
Microbot Medical N/A -76.27%-67.54%

Summary

Microbot Medical beats ClearPoint Neuro on 9 of the 15 factors compared between the two stocks.

Get Microbot Medical News Delivered to You Automatically

Sign up to receive the latest news and ratings for MBOT and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MBOT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

MBOT vs. The Competition

MetricMicrobot MedicalMED INSTRUMENTS IndustryMedical SectorNASDAQ Exchange
Market Cap$188.04M$7.22B$6.21B$10.68B
Dividend YieldN/A1.15%5.72%4.88%
P/E Ratio-4.6027.5729.1427.23
Price / SalesN/A9.86587.91132.66
Price / CashN/A22.2337.5161.65
Price / Book15.715.2912.526.59
Net Income-$11.44M$178.09M$3.32B$276.14M
7 Day Performance-8.56%-0.53%0.77%-0.72%
1 Month Performance-19.34%2.41%7.29%2.47%
1 Year Performance168.29%1.73%64.58%33.90%

Microbot Medical Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
MBOT
Microbot Medical
2.4918 of 5 stars
$2.67
-4.6%
$12.00
+349.4%
+168.2%$188.04MN/A-4.6020Short Interest ↓
Gap Down
CLPT
ClearPoint Neuro
1.1003 of 5 stars
$27.32
+7.6%
$19.67
-28.0%
+88.8%$721.35M$31.39M-33.73110
SIBN
SiBone
3.4069 of 5 stars
$15.22
+3.3%
$23.00
+51.1%
+20.5%$635.90M$167.18M-27.18350
BVS
Bioventus
2.5579 of 5 stars
$7.00
+5.1%
$13.75
+96.4%
-44.1%$578.75M$564.14M-11.481,200
ZIMV
ZimVie
0.7014 of 5 stars
$18.99
flat
$17.75
-6.5%
+33.7%$535.72M$449.75M-27.131,770Upcoming Earnings
High Trading Volume
BFLY
Butterfly Network
2.3156 of 5 stars
$2.36
+11.1%
$3.00
+27.4%
+26.9%$533.69M$82.06M-8.41460Gap Down
AVNS
AVANOS MEDICAL
2.4872 of 5 stars
$11.74
+2.7%
N/A-49.3%$530.84M$687.80M-1.172,227News Coverage
Positive News
Upcoming Earnings
CBLL
CeriBell
2.7025 of 5 stars
$12.50
-1.7%
$32.14
+157.1%
N/A$466M$65.44M-4.18N/ANews Coverage
Analyst Forecast
KIDS
OrthoPediatrics
4.4717 of 5 stars
$17.61
+2.1%
$26.29
+49.3%
-33.0%$432.27M$204.73M-9.84200
DCTH
Delcath Systems
2.5833 of 5 stars
$11.42
-4.6%
$25.33
+121.8%
+3.1%$418.73M$37.21M228.4060Trending News
Analyst Forecast
Analyst Revision
High Trading Volume
TMCI
Treace Medical Concepts
2.4038 of 5 stars
$6.80
+5.6%
$9.67
+42.2%
+29.7%$406.83M$209.36M-8.61250

Related Companies and Tools


This page (NASDAQ:MBOT) was last updated on 10/22/2025 by MarketBeat.com Staff
From Our Partners